Search
+
    SEARCHED FOR:

    HINDALCO INDUSTRIES LTD Q3 RESULTS

    Q2FY25 review: Weak quarter as Nifty delivers just 4% YoY earnings growth; RIL, BPCL among major drags

    India's corporate earnings for Q2 FY25 showed a modest 4% YoY profit growth, slightly surpassing the 3% estimate. This marks the second consecutive quarter of single-digit growth since mid-2020. While key players like SBI, ICICI Bank, and Hindalco boosted earnings, sectors like oil, metals, and energy, including BPCL, JSW Steel, and Reliance, weighed down overall performance, according to MOFSL.

    Grasim shares slip 2% after Q2 PAT declines 66% YoY

    Grasim Industries witnessed a 66% decline in Q2 consolidated net profit, reaching Rs 389 crore, despite an 11% surge in revenue, reaching Rs 33,563 crore. This downturn is attributed to reduced profit margins in the cement sector and initial investments in the 'Birla Opus' paint business.

    Grasim Industries Q2 Results: PAT falls 66% YoY to Rs 390 crore, revenue rises 11%

    Grasim Industries Q2 Results FY25: Grasim Industries, the flagship company of Aditya Birla Group, on Thursday reported a 66% fall in its consolidated net profit at Rs 390 crore in the second quarter, compared with Rs 1164 crore in the last year quarter.

    Hero MotoCorp Q2 Results: Standalone profit rises 14% YoY to Rs 1,204 crore, revenue up 11%

    India's leading two-wheeler maker Hero MotoCorp on Thursday reported 14% growth in its standalone net profit at Rs 1,204 crore in the second quarter. It was Rs 1054 crore in the year-ago quarter.

    Delhivery Q2 Results: Co posts Rs 10 cr profit vs YoY loss, revenue up 13%

    Delhivery reported a net profit of Rs 10 crore in Q2FY25, compared to a loss of Rs 103 crore in Q2FY24. Revenue grew 13% YoY to Rs 2,190 crore. EBITDA increased to Rs 57 crore. Express Parcel revenue grew 7% YoY, and Part Truckload revenue grew 27% YoY.

    PI Industries shares nosedive 9% as Q2 results disappoint Street

    PI Industries Share Price: PI Industries shares dropped 9% despite a 6% YoY rise in Q2 profit, driven by biological growth and improved gross margins. However, domestic revenue saw a decline.

    The Economic Times
    BACK TO TOP